The rise of mul -drug resistant bacterial strains has presented a challenge in the !eld of drug discovery and healthcare, with the discon nua on of now-ineBec ve treatments and the need to develop novel strategies in controlling diseases caused by pathogenic bacteria exempli!ed by Escherichia coli and Salmonella enterica. This report focused on delving into the possibility of compounds prod…